2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer
- PMID: 24847448
- PMCID: PMC4017749
- DOI: 10.1159/000354537
2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer
Abstract
Cervical ultrasound scanning (US) is considered a key examination, by all major thyroid and endocrine specialist societies for the postoperative follow-up of thyroid cancer patients to assess the risk of recurrence. Neck US imaging is readily available, non-invasive, relatively easy to perform, cost-effective, and can guide diagnostic and therapeutic procedures with low complication rates. Its main shortcoming is its operator-dependency. Because of the pivotal role of US in the care of thyroid cancer patients, the European Thyroid Association convened a panel of international experts to review technical aspects, indications, results, and limitations of cervical US in the initial staging and follow-up of thyroid cancer patients. The main aim is to establish guidelines for both a cervical US scanning protocol and US-guided diagnostic and therapeutic procedures in patients with thyroid cancer. This report presents (1) standardization of the US scanning procedure, techniques of US-guided fine-needle aspiration, and reporting of findings; (2) definition of criteria for classification of malignancy risk based on cervical US imaging characteristics of neck masses and lymph nodes; (3) indications for US-guided fine-needle aspiration and for biological in situ assessments; (4) proposal of an algorithm for the follow-up of thyroid cancer patients based on risk stratification following histopathological and cervical US findings, and (5) discussion of the potential use of US-guided localization and ablation techniques for locoregional thyroid metastases.
Keywords: Ethanol injection; Fine-needle aspiration biopsy; Laser therapy; Lymph nodes; Neck ultrasonography; Recurrence risk stratification; Thyroglobulin.
Figures





Similar articles
-
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578. J Laryngol Otol. 2016. PMID: 27841128 Free PMC article.
-
Cystic lymph node metastasis in papillary thyroid carcinoma.Medicina (Kaunas). 2008;44(6):455-9. Medicina (Kaunas). 2008. PMID: 18660640
-
Striving toward standardization of reporting of ultrasound features of thyroid nodules and lymph nodes: a multidisciplinary consensus statement.Thyroid. 2014 Sep;24(9):1341-9. doi: 10.1089/thy.2014.0110. Epub 2014 Jul 23. Thyroid. 2014. PMID: 24967994
-
Advances in ultrasound for the diagnosis and management of thyroid cancer.Thyroid. 2009 Dec;19(12):1363-72. doi: 10.1089/thy.2009.1608. Thyroid. 2009. PMID: 20001718 Review.
-
Good practice guide for cervical ultrasound scan and echo-guided techniques in treating differentiated thyroid cancer of vesicular origin.Ann Endocrinol (Paris). 2011 Jun;72(3):173-97. doi: 10.1016/j.ando.2011.04.001. Epub 2011 Jun 8. Ann Endocrinol (Paris). 2011. PMID: 21641577
Cited by
-
Thyroid ultrasound and its ancillary techniques.Rev Endocr Metab Disord. 2024 Feb;25(1):161-173. doi: 10.1007/s11154-023-09841-1. Epub 2023 Nov 10. Rev Endocr Metab Disord. 2024. PMID: 37946091 Review.
-
Castleman disease mimicking nodal recurrence of thyroid cancer.Endocrine. 2016 Feb;51(2):384-6. doi: 10.1007/s12020-015-0652-4. Epub 2015 Jun 9. Endocrine. 2016. PMID: 26054905
-
Risk factors of malignant fluorodeoxyglucose-avid lymph node on preablation positron emission tomography in patients with papillary thyroid cancer undergoing radioiodine ablation therapy.Medicine (Baltimore). 2019 Apr;98(16):e14858. doi: 10.1097/MD.0000000000014858. Medicine (Baltimore). 2019. PMID: 31008921 Free PMC article.
-
Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies.J Endocrinol Invest. 2018 Jul;41(7):849-876. doi: 10.1007/s40618-018-0884-2. Epub 2018 May 4. J Endocrinol Invest. 2018. PMID: 29729004
-
Recent advances in managing differentiated thyroid cancer.F1000Res. 2018 Jan 18;7:86. doi: 10.12688/f1000research.12811.1. eCollection 2018. F1000Res. 2018. PMID: 29399330 Free PMC article. Review.
References
-
- Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–1214. - PubMed
-
- Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787–803. - PubMed
-
- Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, Brokhin M, Omry G, Fagin JA, Shaha A. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid. 2010;20:1341–1349. - PMC - PubMed
-
- Castagna MG, Maino F, Cipri C, Belardini V, Theodoropoulou A, Cevenini G, Pacini F. Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients. Eur J Endocrinol. 2011;165:441–446. - PubMed
-
- Schlumberger M. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998;338:297–306. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources